Today: 7 February 2026
Subscribe

Digital Turbine stock jumps 20% premarket after outlook raise — what to watch at the open

Digital Turbine stock jumps 20% premarket after outlook raise — what to watch at the open

Digital Turbine shares surged about 20% to $5.93 in premarket trading after the company raised its full-year revenue and profit forecasts. Fiscal third-quarter revenue rose 12% to $151.4 million, with GAAP net income of $5.1 million. Debt fell by over $41 million to $355 million. Investors are watching if the rally holds at the open and how March-quarter demand develops.
4 February 2026
··
UBS stock slides 5% after earnings as buyback and U.S. wealth outflows bite

UBS stock slides 5% after earnings as buyback and U.S. wealth outflows bite

UBS shares fell 5.2% to 35.16 Swiss francs in Zurich after the bank reported a 56% rise in fourth-quarter profit and announced a $3 billion share buyback for 2026. CFO Todd Tuckner warned outflows from the U.S. wealth unit will likely accelerate as advisers leave. UBS’s full-year net profit reached $7.8 billion. The bank’s capital return plans remain tied to pending Swiss regulatory changes.
4 February 2026
··
S&P Global stock tumbled 11% on AI disruption fears — what to watch before earnings

S&P Global stock tumbled 11% on AI disruption fears — what to watch before earnings

S&P Global shares fell 11.3% premarket Wednesday to $468.21 after a broad selloff in data and analytics stocks, triggered by fears that new generative AI tools could erode pricing power. The company recently raised its dividend and confirmed plans to spin off its Mobility division, now branded as Mobility Global, Inc. Gartner, Intuit, and Equifax also dropped over 10%. The S&P 500 closed down 0.84% Tuesday.
4 February 2026
··
Eli Lilly stock in focus before earnings after Novo warns on obesity-drug price squeeze

Eli Lilly stock in focus before earnings after Novo warns on obesity-drug price squeeze

Eli Lilly shares fell 0.5% to $998.50 in premarket trading Wednesday after a 4% drop Tuesday, following Novo Nordisk’s warning of up to a 13% drop in 2026 sales and profits. Novo cut prices and launched an oral Wegovy, while Lilly plans to cap higher-dose obesity drug prices at $399 per month for repeat cash buyers. Investors await Lilly’s Q4 results and comments on pricing and competition.
4 February 2026
···
Bajaj Finserv profit stalls as India’s Q3 results rush hits Trent, Tata Power next

Bajaj Finserv profit stalls as India’s Q3 results rush hits Trent, Tata Power next

Bajaj Finserv’s December-quarter profit was nearly flat at 2,229 crore rupees, despite a 24% jump in revenue to 39,708 crore. Over 140 Indian firms, including Tata Power and Trent, are reporting earnings today. Markets steadied after recent gains, as IT stocks fell sharply. Emcure Pharmaceuticals’ profit rose 50%, while Westlife FoodWorld’s profit dropped 85%.
4 February 2026
········
Enphase Energy stock jumps 23% premarket after outlook; tariffs and tax-credit clock back in focus

Enphase Energy stock jumps 23% premarket after outlook; tariffs and tax-credit clock back in focus

Enphase Energy shares jumped 23% to $45.98 in premarket trading after reporting Q4 revenue of $343.3 million and forecasting Q1 revenue between $270 million and $300 million. U.S. “sell-through” demand rose 21% from the previous quarter, while European revenue fell 29%. BMO raised its rating to “market perform” and set a $41 price target.
4 February 2026
···
Chipotle stock eyes a volatile open after flat 2026 sales outlook and menu price hike plan

Chipotle stock eyes a volatile open after flat 2026 sales outlook and menu price hike plan

Chipotle shares rose 1.7% in premarket trading Wednesday after a 7% drop on its flat 2026 sales outlook and plans for a 1%–2% menu price hike. Fourth-quarter revenue reached about $3.0 billion, with comparable sales down 2.5% and transactions falling 3.2%. Restaurant-level operating margin dropped to 23.4% from 24.8%. Chipotle opened 132 new restaurants in the quarter.
4 February 2026
··
SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion

SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion

Super Micro Computer raised its fiscal 2026 revenue forecast to at least $40 billion, up from $36 billion. Shares edged up 0.1% to $29.67 premarket after December-quarter sales hit $12.7 billion, but gross margin fell to 6.3% from 9.3%. Management cited tariffs, memory shortages, and rising costs as margin pressures. The company projects at least $12.3 billion in sales for the March quarter.
4 February 2026
···
Fresnillo share price dips today after a 6% jump as gold rebounds again — what’s next for FRES.L

Fresnillo share price dips today after a 6% jump as gold rebounds again — what’s next for FRES.L

Fresnillo shares slipped 0.3% to 3,889 pence in early London trading Wednesday, pulling back after a 6.4% surge on Tuesday. Gold and silver prices rose sharply amid U.S.-Iran tensions, while investors awaited Fresnillo’s March 3 results and focused on its trimmed 2026 production outlook. JPMorgan cut its price target to 4,500 pence but kept an “overweight” rating.
4 February 2026
···
AMD stock price slides in premarket as forecast hints at softer quarter, spotlight stays on China chip sales

AMD stock price slides in premarket as forecast hints at softer quarter, spotlight stays on China chip sales

AMD shares fell 7.6% in premarket trading Wednesday after the company forecast a sequential revenue decline and projected first-quarter sales near $9.8 billion. The outlook included $100 million in MI308 AI chip sales to China, with management citing U.S. export controls as a key uncertainty. Data-center revenue rose 39% to $5.4 billion last quarter, but investors focused on AMD’s 55% adjusted gross margin versus Nvidia’s higher target.
4 February 2026
··
SSE PLC share price rises after Q3 update trims FY earnings view; Ofgem price control in focus

SSE PLC share price rises after Q3 update trims FY earnings view; Ofgem price control in focus

SSE Plc shares rose 1.3% after the company cut its full-year earnings forecast to 144-152p per share, citing mixed weather. The utility reported a 7% rise in renewables output and a 64% jump in networks investment to £1.8 billion over nine months. SSE is still considering Ofgem’s RIIO-T3 settlement ahead of a March 3 deadline. Another trading update is due April 2.
4 February 2026
··
Vodafone share price jumps nearly 3% in London as buyback clock ticks and Q3 update looms

Vodafone share price jumps nearly 3% in London as buyback clock ticks and Q3 update looms

Vodafone shares rose 2.7% to 114.45 pence in early London trading Wednesday, ahead of the company’s Q3 FY26 update and investor Q&A set for Thursday. Trading volume reached 13.2 million shares by 09:03 GMT. Vodacom, majority-owned by Vodafone, reported a 13% jump in quarterly service revenue, led by growth in Egypt and Congo. Vodafone’s ongoing share buyback program is due to end Feb. 4.
4 February 2026
·
1 … 57 58 59 60 61 … 1,631

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop